Argyle Capital Management Inc. Has $2.15 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Argyle Capital Management Inc. cut its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 26.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,679 shares of the company's stock after selling 5,250 shares during the quarter. Argyle Capital Management Inc.'s holdings in Procter & Gamble were worth $2,151,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Demars Financial Group LLC raised its holdings in Procter & Gamble by 4.4% in the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company's stock valued at $219,000 after acquiring an additional 63 shares in the last quarter. Emerald Advisors LLC boosted its stake in Procter & Gamble by 1.8% in the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company's stock worth $553,000 after purchasing an additional 65 shares in the last quarter. O Brien Wealth Partners LLC lifted its position in shares of Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company's stock worth $302,000 after purchasing an additional 65 shares in the last quarter. KFA Private Wealth Group LLC increased its holdings in shares of Procter & Gamble by 2.2% in the third quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company's stock valued at $445,000 after purchasing an additional 67 shares in the last quarter. Finally, Chemistry Wealth Management LLC raised its position in Procter & Gamble by 1.2% in the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company's stock worth $856,000 after purchasing an additional 67 shares during the last quarter. Institutional investors own 65.77% of the company's stock.

Insider Buying and Selling

In related news, CEO R. Alexandra Keith sold 776 shares of the firm's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares of the company's stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 45,000 shares of the firm's stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the sale, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The disclosure for this sale can be found here. Insiders sold 100,865 shares of company stock valued at $16,029,280 over the last 90 days. Company insiders own 0.17% of the company's stock.

Procter & Gamble Stock Down 0.8 %

NYSE PG traded down $1.26 during trading hours on Friday, reaching $161.29. 5,659,784 shares of the company's stock traded hands, compared to its average volume of 6,820,118. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The firm has a 50-day simple moving average of $159.64 and a 200 day simple moving average of $153.65. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $164.32. The firm has a market cap of $380.67 billion, a PE ratio of 26.35, a PEG ratio of 3.27 and a beta of 0.44.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same period in the prior year, the company posted $1.37 earnings per share. The company's quarterly revenue was up .6% on a year-over-year basis. Sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. This is an increase from Procter & Gamble's previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date is Thursday, April 18th. Procter & Gamble's dividend payout ratio (DPR) is 65.69%.

Analyst Ratings Changes

PG has been the subject of a number of recent research reports. UBS Group boosted their target price on Procter & Gamble from $172.00 to $178.00 and gave the stock a "buy" rating in a research report on Wednesday, January 24th. Raymond James lifted their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an "outperform" rating in a report on Wednesday, January 24th. Stifel Nicolaus upped their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a "hold" rating in a research note on Wednesday, January 24th. The Goldman Sachs Group started coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They issued a "neutral" rating and a $168.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Procter & Gamble from $172.00 to $171.00 and set a "buy" rating on the stock in a research note on Monday, April 22nd. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average target price of $169.76.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.